StonvexLoading…
StonvexStonvexStonvexCore line items from GNTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $675.44M | $2.53B | $1.89B | $1.23B |
Operating Income | $123.66M | $473.94M | $353.83M | $231.51M |
Net Income | $98.46M | $384.84M | $291.88M | $190.91M |
EPS (Diluted) | $0.46 | $1.74 | $1.31 | $0.85 |
Total Assets | $3.00B | $2.93B | $2.94B | $2.81B |
Total Liabilities | $492.03M | $437.66M | $441.22M | $380.69M |
Cash & Equivalents | $164.76M | $145.65M | $178.59M | $119.77M |
Free Cash Flow OCF − CapEx | $120.04M | $458.04M | $358.21M | $246.81M |
Shares Outstanding | 211.46M | 215.45M | 219.35M | 221.39M |